Covidien to buy Somanetics for $250M

MANSFIELD – Covidien Plc said Wednesday it will buy Somanetics Corp., a maker of cardiac surgery equipment, for $250 million. Covidien said it will pay $25 a share in cash for Troy, Mich.-based Somanetics, a 32 percent premium over the company’s closing price of $18.90 on Tuesday, The Associated Press reported. The $250 million cost…

Want More Free?

To access 2 more articles, please log in or register for free.

Registered users get access to a limited number of free articles every month.

Register Now

Already registered? Login to access more free articles.

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -